Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKinsey
Harvard Business School
Medtronic
AstraZeneca

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Litigation for ALEMTUZUMAB

See Plans and Pricing

« Back to Dashboard

US Court Litigation for ALEMTUZUMAB

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
5,846,534   Start Trial   Start Trial 2016-07-07 2017-05-05 28:2201 Declaratory Judgment District Court, C.D. California Both   Start Trial
5,846,534   Start Trial   Start Trial 2016-07-07 28:2201 Declaratory Judgment District Court, C.D. California Plaintiff   Start Trial
6,120,766   Start Trial   Start Trial 2015-11-05 28:1332bc Diversity-Breach of Contract District Court, S.D. New York Plaintiff   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for ALEMTUZUMAB

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
9,352,037 Forty Seven, Inc.   Start Trial 2016-08-05 2016-08-05 van den Berg Inter partes review   Start Trial 2017-02-09   Start Trial
9,352,037 Forty Seven, Inc.   Start Trial 2016-08-08 2016-08-08 van den Berg Inter partes review   Start Trial 2017-02-09   Start Trial
9,352,037 Forty Seven, Inc.   Start Trial 2018-01-08 2018-01-08 van den Berg, Timo Kars Inter partes review   Start Trial   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Mallinckrodt
Harvard Business School
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.